Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda

Today, 6:25 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14)

1 minute read

Today, 6:25 AM

Oppenheimer analyst Suraj Kalia maintains ResMed (NYSE:RMD) with a Outperform and raises the price target from $240 to $270.

32 minute read

Today, 6:25 AM

During the morning session on Wednesday, 398 stocks hit new 52-week highs. Interesting Highlights: Alphabet (NASDAQ:GOOGL) was the largest company…